Tuberculosis vaccines comprising antigens expressed during the latent infection phase

Details for Australian Patent Application No. 2006261445 (hide)

Owner Statens Serum Institut

Inventors Aagaard, Claus; Andersen, Peter; Vingsbo-Lundberg, Carina

Agent FB Rice

Pub. Number AU-B-2006261445

PCT Pub. Number WO2006/136162

Priority PA2005 00924 23.06.05 DK; PA 2005 01393 05.10.05 DK

Filing date 20 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 31 March 2011

International Classifications

C07K 14/35 (2006.01) Peptides having more than 20 amino acids

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

A61P 31/06 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

24 January 2008 PCT application entered the National Phase

  PCT publication WO2006/136162 Priority application(s): WO2006/136162

31 March 2011 Application Accepted

  Published as AU-B-2006261445

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261446-A solar water heating system

2006261444-Amylases for pharmaceutical use